0001104659-22-114412.txt : 20221103
0001104659-22-114412.hdr.sgml : 20221103
20221103160520
ACCESSION NUMBER: 0001104659-22-114412
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221101
FILED AS OF DATE: 20221103
DATE AS OF CHANGE: 20221103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hahn Mark W
CENTRAL INDEX KEY: 0001408502
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38067
FILM NUMBER: 221357896
MAIL ADDRESS:
STREET 1: 6340 QUADRANGLE DRIVE
STREET 2: SUITE 100
CITY: CHAPEL HILL
STATE: NC
ZIP: 27517
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Verona Pharma plc
CENTRAL INDEX KEY: 0001657312
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3 MORE LONDON RIVERSIDE
CITY: LONDON
STATE: X0
ZIP: SE1 2RE
BUSINESS PHONE: 011-44-0-2032834200
MAIL ADDRESS:
STREET 1: 3 MORE LONDON RIVERSIDE
CITY: LONDON
STATE: X0
ZIP: SE1 2RE
4
1
tm2229640-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-11-01
0
0001657312
Verona Pharma plc
VRNA
0001408502
Hahn Mark W
3 MORE LONDON RIVERSIDE
LONDON
X0
SE1 2RE
UNITED KINGDOM
0
1
0
0
Chief Financial Officer
Ordinary Shares
2022-11-01
4
F
0
454856
1.6
D
17458640
D
Ordinary Shares
2022-11-01
4
S
0
13160
1.6726
D
17445480
D
Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
Represents the number of Ordinary Shares withheld to satisfy the tax withholding obligation in connection with the vesting of certain previously reported Restricted Share Units.
The price reported represents the closing price of the Issuer's ADSs on the Nasdaq Stock Market LLC on October 31, 2022 divided by eight (8).
The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover taxes in connection with the vesting of certain previously reported Restricted Share Units.
The price reported represents the sale price of the ADSs divided by eight (8).
Consists of (i) 9,413,016 Ordinary Shares underlying RSUs (which are represented by 1,176,627 ADSs); and (ii) 8,032,464 Ordinary Shares underlying 1,004,058 ADSs.
/s/ Claire Poll, Attorney-in-fact for Mark Hahn
2022-11-03